All content for The Bio Report is the property of Levine Media Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Punit Dhillon, president and CEO of Skye Bioscience, discusses the limits of GLP-1 obesity therapies, the company’s experimental obesity therapy that works on a different target, and the potential to combine it with GLP-1 agonists and other therapeutic approaches.
